Davidson Michael H.
Director
CIK: 1573785
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 443,707 | $33.25 | $14,753,257.75 | View Details Filing |
| Feb 26, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 165,408 | $33.63 | $5,562,671.04 | View Details Filing |
| Feb 26, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 17,924 | $34.44 | $617,302.56 | View Details Filing |
| Feb 25, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 1,300 | $36.68 | $47,684.00 | View Details Filing |
| Feb 25, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 46,517 | $35.11 | $1,633,211.87 | View Details Filing |
| Feb 25, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 10,436 | $35.96 | $375,278.56 | View Details Filing |
| Feb 24, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 3,161 | $36.46 | $115,250.06 | View Details Filing |
| Feb 24, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | S | 61,547 | $36.13 | $2,223,693.11 | View Details Filing |